Cognate Bioservices, A Charles River Company

Cognate Bioservices, A Charles River Company company information, Employees & Contact Information

Cognate BioServices is a leading contract development and manufacturing organization specialized in cell and cell-mediated gene therapies. We pride ourselves in the level of quality and experience we bring to the table. Cognate is a dynamic, results-driven, organization focused on providing the broadest range of commercialization services to regenerative medicine, cellular immunotherapy and advance cell therapy companies, organizations and institutions. Cognate provides a unique combination of custom services to companies across all points of clinical and commercial development ranging from early preclinical studies, to mid phase trials and product scale-up though later stage clinical trials and bridging into commercial manufacturing. Cognate applies the know-how and expertise of its business, scientific and technical teams to successfully develop autologous and allogeneic products across multiple cell-based technology platforms from start to finish.
Looking for a particular Cognate Bioservices, A Charles River Company employee's phone or email?

Cognate Bioservices, A Charles River Company Questions

News

Cognate BioServices Reveals New Brand Identity with Redesigned Logo and Website - PR Newswire

Cognate BioServices Reveals New Brand Identity with Redesigned Logo and Website PR Newswire

Cognate BioServices Names Tom Pamukcoglu As VP, Global Head Of Quality - Pharmaceutical Online

Cognate BioServices Names Tom Pamukcoglu As VP, Global Head Of Quality Pharmaceutical Online

Charles River jumps into cell and gene therapy manufacturing with $875M Cognate buy - Fierce Pharma

Charles River jumps into cell and gene therapy manufacturing with $875M Cognate buy Fierce Pharma

Cognate BioServices Announces Major Expansion of Manufacturing Facilities in US and Europe - PR Newswire

Cognate BioServices Announces Major Expansion of Manufacturing Facilities in US and Europe PR Newswire

Charles River Acquires Cell and Gene Therapy CDMO Cognate for $875M - Genetic Engineering and Biotechnology News

Charles River Acquires Cell and Gene Therapy CDMO Cognate for $875M Genetic Engineering and Biotechnology News

Cognate BioServices closes Series B and completes acquisition of Cobra Biologics - PR Newswire

Cognate BioServices closes Series B and completes acquisition of Cobra Biologics PR Newswire

EY Announces J. Kelly Ganjei of Cognate BioServices, Inc. as an Entrepreneur Of The Year® 2020 Southeast Award Finalist - PR Newswire

EY Announces J. Kelly Ganjei of Cognate BioServices, Inc. as an Entrepreneur Of The Year® 2020 Southeast Award Finalist PR Newswire

Cognate BioServices announces acquisition of Cobra Biologics - PR Newswire

Cognate BioServices announces acquisition of Cobra Biologics PR Newswire

Top Cognate Bioservices, A Charles River Company Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant